Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil

Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil

Abstract Background The aim of this study was to evaluate disease activity among patients with axial spondyloarthritis (AS) treated with tumor necrosis factor inhibitors (TNFi) and/or nonsteroidal anti-inflammatory drugs (NSAIDs) for at least 12 weeks in private outpatient settings in Brazil. Method...

Full description

Bibliographic Details
Main Authors: Ricardo Acayaba de Toledo, Felipe Merchan Ferraz Grizzo, Vander Fernandes, Renato Calheiros, Ricardo T. Russo, Gustavo Rosal, Luiz Roberto Delboni Marchese, Roberto Tunala, Renato Watanabe, Marina Gabriela Birck, Guilherme Silva Julian, Francisco Jose Forestiero
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Advances in Rheumatology
Subjects:
Ankylosing spondylitis
Axial radiographic spondyloarthritis
Disease activity
Nonsteroidal anti-inflammatory drug
Patient-reported outcome
Real-world study
Online Access:https://doi.org/10.1186/s42358-022-00270-3

Similar Items

Similar Items